Oxysterols and neurodegenerative diseases

Molecular Aspects of Medicine

Volumn 30, Issue 3, 2009, Pages 171-179

  Björkhem, Ingemar ^a   Cedazo Minguez, Angel ^a   Leoni, Valerio ^b   Meaney, Steve ^c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b DEPARTMENT OF NEUROSURGERY   (Italy)

^c DUBLIN INSTITUTE OF TECHNOLOGY   (Ireland)

Author keywords

Amyloid; 24S Hydroxycholesterol; 27 Hydroxycholesterol; Activity regulated cytoskeleton associated protein; Blood brain barrier; CYP27; CYP46

Indexed keywords

26 HYDROXYCHOLESTEROL; BIOLOGICAL MARKER; CHOLESTEROL; OXYSTEROL;

ALZHEIMER DISEASE; ASTROCYTE; CEREBROSPINAL FLUID; CHEMICAL STRUCTURE; CIRCULATION; DEGENERATIVE DISEASE; ENZYME ACTIVITY; ENZYME METABOLISM; ENZYME REGULATION; ENZYME SYNTHESIS; HUMAN; HYPERCHOLESTEROLEMIA; MEMORY; NERVE CELL; NERVE DEGENERATION; NONHUMAN; REVIEW;

AMYLOID BETA-PROTEIN; BLOOD-BRAIN BARRIER; CYTOSKELETAL PROTEINS; HUMANS; HYDROXYCHOLESTEROLS; NERVE TISSUE PROTEINS; NEURODEGENERATIVE DISEASES;

RATTUS;

EID: 67349094556     PISSN: 00982997     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mam.2009.02.001     Document Type: Review

References (57)

1. Abildayeva P., Jansen P.J., Hirsch-Reinshagen V., Bloks V.W., Bakker A.H., Ramaekers F.C., Devente J., Groen A.K., Wellington C.L., Kuipers F., and Mulder M. 24S-hydroxycholesterol participates in LXR-controlled pathway in astrocytes that regulate ApoE-mediated cholesterol efflux. J. Biol. Chem. 281 (2006) 12799-12808
2. Arvanitakis Z., Schneider J.A., Wilson R.S., Bienias J.L., Kelly J.F., Evans D.A., and Bennett D.A. Statins, incident Alzheimer's disease, change in cognitive function, and neuropathology. Neurology 70 (2008) 1795-1802
3. Babiker A., Andersson O., Lund E., Xiu R.-J., Deeb S., Reshef A., Leitersdorf E., Diczfalusy U., and Björkhem I. Elimination of cholesterol in endothelial cells and macrophages by the sterol 27-hydroxylase mechanism. J. Biol. Chem. 272 (1997) 26253-26261
4. Björkhem I., and Meaney S. Brain cholesterol: long secret life behind a barrier. Arterioscl. Thromb. Vasc. Biol. 24 (2004) 806-815
5. Björkhem I., Lütjohann D., Breuer O., Sakinis A., and och Wennmalm A. Importance of a novel oxidative mechanism for elimination of brain cholesterol. J. Biol. Chem. 272 (1997) 30178-30184
6. Björkhem I., Lütjohann D., Diczfalusy U., Ståhle L., Ahlborg G., and Wahren J. Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of this oxysterol in the circulation. Lipid Res. 39 (1998) 1594-1600
7. Björkhem I., Andersson U., Ellis E.C.S., Alvelius G., Ellegård L., Diczfalusy U., Sjövall J., and Einarsson C. From brain to bile. Evidence that conjugation and -hydroxylation are important for elimination of 24S-hydroxycholesterol in man. J. Biol. Chem. 276 (2001) 37004-37010
8. Björkhem I., Heverin M., Leoni V., Meaney S., and Diczfalusy U. Oxysterols and Alzheimer's disease. Acta Neurol. Scand. 185 (2006) 43-49
9. Blennow K., Wallin A., Fredman P., Karolsson I., Gottfries C.G., and Svennerholm L. Blood-brain barrier disturbances in patients with Alzheimer's disease is related to vascular factors. Acta Neurol. Scand. 81 (1990) 323-326
10. Bogdanovic N., Bretillon L., Lund E.G., Diczfalusy U., Lannfelt L., Winblad B., Russell D.W., and Björkhem I. Induction of cholesterol catabolic enzyme cholesterol 24S-hydroxylase (CYP46) in Alzheimer brain. Neurosci. Lett. 314 (2001) 45-48
11. Brétillon L., Lütjohann D., Ståhle L., Widhe T., Bindl L., Eggertsen G., Diczfalusy U., and Björkhem I. Plasma levels of 24S-hydroxycholesterol reflect the balance between cerebral production and hepatic metabolism and are inversely related to body surface. J. Lipid Res. 41 (2000) 840-845
12. Bretillon L., Sidén A., Wahlund L., Lütjohann D., Crisby M., Hillert J., Groth C.-G., Diczfalusy U., and Björkhem I. Plasma levels of 24S-hydroxycholesterol in neurological patients. Neurosci. Lett. 293 (2000) 87-90
13. Bretillon L., Diczfalusy U., Björkhem I., Maire M.A., Joffre C., Acar N., Bron A., and Creuzot-Garcher C. Cholesterol 24S-hydroxylase is specifically expressed in neurons of the neural retina. Curr. Eye Res. 32 (2007) 361-366
14. Brown J., Theisler C., Silberman S., Magnuson D., Gottardi-Littell N., Lee J.M., Reiss A.B., Eckman C.B., and Wolozin B. Differential expression of cholesterol hydroxylases in Alzheimer's disease. J. Biol. Chem. 279 (2004) 34674-34681
15. Dietschy J.M., and Turley S.D. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J. Lipid Res. 45 (2004) 1375-1397
16. Famer D., Meaney S., Mousavi M., Björkhem I., and Crisby M. Regulation of α-and β-secretase activity by oxysterols: cerebrosterol stimulates processing of APP via the -secretase pathway. Biochem. Biophys. Res. Commun. 359 (2007) 46-50
17. Ginsberg S.D., Hemby S.E., Lee V.M., Eberwine J.H., and Trojanowski J.Q. Expression profile of transcripts in Alzheimer's disease tangle-bearing CA1 neurons. Ann. Neurol. 48 (2000) 77-87
18. Guzowski J.F., Lyford G.L., Stevenson G.D., Houston F.P., McGaugh J.L., Worley P.F., and Barnes C.A. Inhibition of activity-dependent arc protein expression in rat hippocampus impairs the maintenance of long-term potentiation and the consolidation of long-term memory. J. Neurosci. 20 (2000) 3993-4001
19. Heverin M., Bogdanovic N., Lütjohann D., Bayer T., Pikuleva I., Bretillon L., Diczfalusy U., Winblad B., and Björkhem I. Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease. J. Lipid Res. 45 (2004) 186-193
20. Heverin M., Meaney S., Lütjohann D., Diczfalusy U., Wahren J., and Björkhem I. Crossing the barrier: net flux of 27-hydroxycholesterol into the human brain and possible consequences for cerebral cholesterol homeostasis. J. Lipid Res. 46 (2005) 1047-1052
21. Jick H., Zornberg G.L., Jick S.S., Seshadri S., and Drachman D.A. Statins and the risk of dementia. Lancet 356 (2000) 1627-1631
22. Karrenbauer V.D., Leoni V., Lim E.T., Giovanni G., Gle G.T., Sastre-Garriga J., Thompson A.J., Rashid W., Davies G., Miller D.H., Björkhem I., and Masterman T. Plasma cerebrosterol and magnetic resonance imaging measures in multiple sclerosis. Clin. Neurol. Neurosur. 108 (2006) 456-460
23. Karu K., Hornshaw M., Woffendin G., Bodin K., Hamberg M., Alvelus G., Sjövall J., Turton J., Wang Y., and Griffith W.J. Liquid chromatography-mass spectrometry utilizing multistage fragmentation for the identification of oxysterols. J. Lipid Res. 48 (2007) 976-987
24. Kölsch H., Heun R., Kerksiek A., Bergmann K.V., Maier W., and Lutjohann D. Alterated levels of plasma 24S- and 27-hydroxycholesterol in demented patients. Neurosci. Lett. 368 (2004) 303-308
25. Kotti T.J., Ramirez D.M., Pfeiffer B.E., Huber K.M., and Russell D.W. Brain cholesterol turnover required for geranylgeraniol production and learning in mice. Proc. Natl. Acad. Sci. USA 103 (2006) 3869-3874
26. Leoni V., Mastermann T., Diczfalusy U., DeLuca F., Hillert J., and Björkhem I. Changes in plasma levels of the brain specific oxysterol 24S-hydroxycholesterol reflect progression of multiple sclerosis. Neurosci. Lett. 331 (2002) 163-166
27. Leoni V., Masterman T., Patel P., Meaney S., Diczfalusy U., and Björkhem I. Side-chain oxidized oxysterols in cerebrospinal fluid and integrity of the blood-brain and blood-cerebrospinal fluid barriers. J. Lipid Res. 44 (2003) 793-799
28. Leoni V., Masterman T., Mousavi F., Wretlind B., Wahlund L.-O., Diczfalusy U., Hillert J., and Björkhem I. Diagnostic use of cerebral and extracerebral oxysterols. Clin. Chem. Lab. Med. 42 (2004) 186-191
29. Leoni V., Shaafati M., Salomon A., Kivipelto M., Björkhem I., and Wahlund L.-O. Are the CSF levels of 24S-hydroxycholesterol a suitable biomarker for mild cognitive impairment?. Neurosci. Lett. 397 (2006) 83-87
30. Leoni V., Mariotti C., Tabrizi S.J., Valenza M., Wild E.J., Henely S.M., Hobbs N.Z., Mandelli M.L., Grisoli M., Björkhem I., Cattaneo E., and Di Donato S. Plasma 24S-hydroxycholesterol and caudate MRI in premanifest and early Huntington's disease. Brain 131 (2008) 2851-2859
31. Locatelli S., Lutjohann D., Schmidt H.H., Otto C., Beisiegel U., and vonBergmann U. Reduction of plasma 24S-hydroxycholesterol levels using high-dosage simvastatin in patients with hypercholesterolemia: evidence that simvastatin affects cholesterol metabolism in the human brain. Arch. Neurol. 59 (2002) 213-216
32. Lund E.G., Guileyardo J.M., and Russell D.W. CDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain. Proc. Natl. Acad. Sci. USA 96 (1999) 7238-7243
33. Lund E.G., Xie C., Kotti T., Turley S.D., Dietschy J., and Russell D.W. Knockout of the cholesterol 24-hydroxylase gene in mice reveals a brain-specific mechanism of cholesterol turnover. J. Biol. Chem. 278 (2003) 22980-22988
34. Lütjohann D., Breuer O., Ahlborg G., Nennesmo I., Sidén A., Diczfalusy U., and Björkhem I. Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation. Proc. Natl. Acad. Sci. USA 93 (1996) 9799-9804
35. Mast N., Norcross R., Andersson U., Shov M., Nakayama K., Björkhem I., and Pikuleva I. Broad substrate specificity of human cytochrome P-450 which initiates cholesterol degradation in the brain. Biochemistry 42 (2003) 14284-14292
36. Mast N., White M.A., Björkhem I., Johnson E.F., Stout C., and Pikuleva I. Crystal structure of substrate-bound and substrate-free cytochrome P-450 46A1 the principal cholesterol-hydroxylase in the brain. Proc. Natl. Acad. Sci. USA 105 (2008) 9546-9551
37. Mateos L., Akterin S., Gil-Bea F.J., Spulber S., Rahman A., Björkhem I., Schultzberg M., Flores-Morales A., and Cedazo-Minguez A. Activity-regulated cytoskeleton-associated protein in rodent brain is down-regulated by high fat diet in vivo and by 27-hydroxycholesterol in vitro. Brain Pathol. 19 (2009) 69-80
38. Meaney S., Heverin M., Panzenboeck U., Ekström L., Axelson M., Andersson U., Diczfalusy U., Pikuleva I., Wahren J., and Björkhem I. Novel route for elimination of brain oxysterols across the blood-brain barrier: conversion into 7alpha-hydroxy-3-oxo-4-cholestenoic acid. J. Lipid Res. 48 (2007) 944-951
39. Milagre I., Nunes M.J., Gama M.J., Silva R.F., Pascussi J.M., Lechner M.C., and Rodrigues E. Transcriptional regulation of the human CYP46A1 brain-specific expression of Sp transcription factors. J. Neurochem. 106 (2008) 835-849
40. Ohyama Y., Meaney S., Heverin M., Ekström L., Brafman A., Andersson A., Olin M., Eggertsen G., Diczfalusy U., Feinstein E., and Björkhem I. Studies on the transcriptional regulation of cholesterol 24-hydroxylase (CYP46A1): marked insensitivity towards different regulatory axes. J. Biol. Chem. 281 (2006) 3810-3820
41. Papassotiropoulos A., Lutjohann D., Bagli M., Locatelli S., Jessen F., Buschfort R., Ptok U., Björkhem I., vonBergmannHeun K., and Heun R. 24S-Hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia. Psychiatr. Res. 36 (2002) 27-32
42. Pfrieger F.W. Outsourcing in the brain: do neurons depend on cholesterol delivery by astrocytes?. Bioessays 60 (2003) 1158-1171
43. Puglielli L., Tanzi R.E., and Kovacs D.M. Alzheimer's disease: the cholesterol connection. Nat. Neurosci. 6 (2003) 345-351
44. Qing H., He G., Ly P., Fox C.J., Staufenbiel M., Cai F., Zhang Z., Wei S., Sun X., Chen C.-H., Zhou W., Wang H., and Song W. Valproic acid inhibits Aβ production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models. J. Exp. Med. 205 (2008) 2781-2789
45. Riddell D.R., Zhou H., Comery T.A., Kouranova E., Lo C.F., Warwick H.K., Ring R.H., Kirksey Y., Aschmies S., Xu J., Kubek K., Hirst W.D., Gonzales C., Chen Y., Murphy E., Leonard S., Vasylyev D., Oganesian A., Martone R.L., Pangalos M.N., Reinhart P.H., and Jacobsen J.S. The LXR-agonist TO901317 selectively lowers hippocampal Aβ42 and improves memory in the TG2576 mouse model of Alzheimer's disease. Mol. Cell Neurosci. 34 (2007) 621-628
46. Shafaati M., Solomon A., Kivipelto M., Björkhem I., and Leoni V. Levels of ApoE in cerebrospinal fluid are correlated with Tau and 24S-hydroxycholesterol in patients with cognitive disorders. Neurosci. Lett. 425 (2007) 78-82
47. Shafaati M., ÓDriscoll R., Björkhem I., and Meaney S. Transcriptional regulation of cholesterol 24S-hydroxylase by histone deacetylase inhibitors. Biochem. Biophys. Res. Commun. 378 (2009) 689-694
48. Simons M., Keller P., DeStrooper B., Beyreuther K., Dotti C.G., and Simons K. Cholesterol depletion inhibits the generation of β-amyloid in hippocampal neurons. Proc. Natl. Acad. Sci. USA 95 (1998) 6460-6464
49. Teunissen C.E., Dijkstra C.D., Polman C.H., Hoogervorst E.L., von Bergmann K., and Lutjohann D. Decreased levels of brain specific 24S-hydroxycholesterol and cholesterol precursors in serum of multiple sclerosis patients. Neurosci. Lett. 347 (2003) 159-162
50. Teunissen C.E., Floris S., Sonke K.E., Dijkstra C.D., DeVries H.E., and Lutjohann D. 24S-Hydroxycholesterol in relation to disease manifestation of acute experimental autoimmune encephalomyelitis. Neurosci. Res. 85 (2007) 1499-1505
51. Valenza M., Carroll J.B., Leoni V., Bertram L.N., Björkhem I., Singaraja R.R., Di Donato S., Lutjohann D., Hayden M.R., and Catteano E. Cholesterol biosynthesis pathway is disturbed in YAC128 mice and is modulated by huntingtin mutation. Hum. Mol. Genet. 16 (2007) 2187-2198
52. Valenza M., Leoni V., Tarditi A., Mariotti C., Björkhem I., Di Donato S., and Catteano E. Progressive dysfunction of the cholesterol biosynthesis pathway in the R6/2 mouse model of Huntington's disease. Neurobiol. Dis. 28 (2007) 133-142
53. Wang N., Yvan-Charvet L., Lutjohann D., Mulder M., Vabmierlo T., Kim T.W., and Tall A.R. ATP-binding cassette transporters G1 and G4 mediate cholesterol and desmosterol efflux to HDL and regulate sterol accumulation in the brain. FASEB J. 22 (2008) 1073-1082
54. Wechsler A., Brafman A., Shafir M., Heverin M., Gottlieb H., Damari G., Spivak I., Moshkin O., Fridman E., Skaliter R., Einat P., Faerman A., Björkhem I., and Feinstein E. Generation of cholesterol-free mouse by genetic inactivation of desmosterol reductase. Science 302 (2003) 2087
55. Wolozin B., Kellman W., Ruosseau P., Celesia G.G., and Siegel G. Decreased prevalence of Alzheimer's disease associated with HMG CoA reductase inhibitors. Arch. Neurol. 57 (2000) 1439-1443
56. Xie C., Lund E.G., Turley S.D., Russell D.W., and Dietschy J.M. Quantitation of two pathways for cholesterol excretion in normal mice and mice with neurodegeneration. J. Lipid Res. 44 (2003) 1780-1789
57. Yau J.L., Rasmuson S., Andrew R., Graham M., Noble J., Olson T., Fuchs E., Lathe R., and Seckl J.R. Dehydroepiandrosterone 7-hydroxylase CYP7B1: predominant expression in primate hippocampus and reduced expression in Alzheimer's disease. Neuroscience 121 (2003) 307-314